WHO ICTRP trial
EFECTO DEL ÁCIDO ACETILSALICÍLICO EN LA PROLIFERACIÓN Y APOPTOSIS CELULAR DEL…
EUCTR2005-003122-25-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2005-003122-25-ES |
|---|---|
| Public title | EFECTO DEL ÁCIDO ACETILSALICÍLICO EN LA PROLIFERACIÓN Y APOPTOSIS CELULAR DEL EPITELIO METAPLÁSICO DEL ESÓFAGO DE BARRETT |
| Scientific title | EFECTO DEL ÁCIDO ACETILSALICÍLICO EN LA PROLIFERACIÓN Y APOPTOSIS CELULAR DEL EPITELIO METAPLÁSICO DEL ESÓFAGO DE BARRETT |
| Primary sponsor | ANGEL LANAS |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Spain |
| Conditions | Esófago de Barrett. |
| Interventions | Product Name: ACIDO ACETILSALICILICO Pharmaceutical Form: Tablet INN or Proposed INN: ACIDO ACETILSALICÍLICO Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 100- Product Name: OMEPRAZOL Pharmaceutical… |
| Registration date | Sep 30, 2005 |
| Secondary IDs | ICS-1-05 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: